Patients Self-Administer Protein in Nose Drops to Treat Kaposi's Sarcoma

University of Pennsylvania Cancer Center
Ultima Vez Modificado: 16 de mayo del 1999

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Bevacizumab Active in HIV-Linked Kaposi's Sarcoma

Mar 20, 2012

Phase 2 study shows overall response rate of 31 percent in patients with poor-prognosis HIV-KS

Ridaforolimus Promising for Treating Advanced Sarcomas

Nov 9, 2011

Clinical benefit seen for patients with advanced sarcomas of different histopathologic subtypes

FDA Approves Yondelis for Soft-Tissue Sarcoma

Oct 25, 2015

Drug sanctioned for liposarcoma or leiomyosarcoma